Efficacy of structured exercise and oat supplementation for treating non-alcoholic fatty liver disease: protocol of a randomized controlled trial

被引：0

作者：

Jiahui Yin ^{[1
]}

Lianying Wang ^{[1
]}

Ran Li ^{[2
]}

Xiaoguang Cheng ^{[3
]}

Haibo Wang ^{[4
]}

Yufeng Li ^{[5
]}

机构：

[1] Beijing Friendship Hospital Pinggu Campus,Department of Endocrinology

[2] Capital Medical University,Sport Science School

[3] Beijing Sport University,Department of Radiology

[4] Beijing Jishuitan Hospital,Peking University Clinical Research Institute

[5] Peking University First Hospital,Key Laboratory of Epidemiology of Major Diseases (Peking University)

[6] Ministry of Education,undefined

来源：

Nutrition Journal | / 24卷 / 1期

关键词：

Non-alcoholic fatty liver disease; Structured exercise; Diet intervention; Randomized controlled study;

D O I：

10.1186/s12937-025-01128-2

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] A randomized controlled trial of kalmegh supplementation on non-alcoholic fatty liver disease
Nandekar, Sanket
Kumar, Sunil
Yadav, Devesh
Sen, Binay
Gadge, Pournima
JOURNAL OF HEPATOLOGY, 2023, 78 : S830 - S830
[2] EFFICACY OF EZETIMIBE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED, CONTROLLED TRIAL
Takeshita, Y.
Takamura, T.
Kita, Y.
Misu, H.
Arai, K.
Yamashita, T.
Mizukoshi, E.
Kaneko, S.
JOURNAL OF HEPATOLOGY, 2011, 54 : S346 - S346
[3] Flaxseed powder supplementation in non-alcoholic fatty liver disease: a randomized controlled clinical trial
Tian, Yanyan
Zhou, Yuhao
Liao, Wang
Xia, Jiayue
Hu, Qiaosheng
Zhao, Qing
Zhang, Rui
Sun, Guiju
Yang, Ligang
Li, Lihua
FOOD & FUNCTION, 2025, 16 (04) : 1389 - 1406
[4] Efficacy of silymarin in patients with non-alcoholic fatty liver disease - the Siliver trial: a study protocol for a randomized controlled clinical trial
de Avelar, Camila Ribeiro
Nunes, Beatriz Vieira Coelho
Sassaki, Betina da Silva
Vasconcelos, Mariana dos Santos
de Oliveira, Lucivalda Pereira Magalhaes
Lyra, Andre Castro
Bueno, Allain Amador
de Jesus, Rosangela Passos
TRIALS, 2023, 24 (01)
[5] Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial
Camila Ribeiro de Avelar
Beatriz Vieira Coelho Nunes
Betina da Silva Sassaki
Mariana dos Santos Vasconcelos
Lucivalda Pereira Magalhães de Oliveira
André Castro Lyra
Allain Amador Bueno
Rosângela Passos de Jesus
Trials, 24
[6] Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial
贾国瑜
China Medical Abstracts(Internal Medicine), 2018, 35 (02) : 107 - 108
[7] Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Haukeland, John Willy
Konopski, Zbigniew
Eggesbo, Heidi Beate
Von Volkmann, Hilde Loland
Raschpichler, Gabriele
Bjoro, Kristian
Haaland, Terese
Loberg, Else Marit
Birkeland, Kare
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 853 - 860
[8] Correction to: Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial
Lu-Lu Gao
Yu-Xiang Li
Jia-Min Ma
Yi-Qiong Guo
Lin Li
Qing-Han Gao
Yan-Na Fan
Meng-Wei Zhang
Xiu-Juan Tao
Jian-Qiang Yu
Jian-Jun Yang
Trials, 22
[9] Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
Jennifer E. Lambert
Jill A. Parnell
Bertus Eksteen
Maitreyi Raman
Marc R. Bomhof
Kevin P. Rioux
Karen L. Madsen
Raylene A. Reimer
BMC Gastroenterology, 15
[10] Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
Lambert, Jennifer E.
Parnell, Jill A.
Eksteen, Bertus
Raman, Maitreyi
Bomhof, Marc R.
Rioux, Kevin P.
Madsen, Karen L.
Reimer, Raylene A.
BMC GASTROENTEROLOGY, 2015, 15

← 1 2 3 4 5 →